Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells.
Parthenolide is a major sesquiterpene lactone derived from feverfew (Tanacetum parthenium) with known anti-inflammatory activity. Moreover, the anticancer potential of this compound was suggested. In this study, we determined the effect of parthenolide on proliferation of three human cancer cell lines: human lung carcinoma (A549), human medulloblastoma (TE671), human colon adenocarcinoma (HT-29) and human umbilical vein endothelial cells (HUVEC) in vitro. Cell proliferation was assessed by means of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The IC(50) value (the concentration of drug necessary to induce 50% inhibition) together with confidence limits was calculated. Parthenolide inhibited proliferation of all three types of cancer cells (A549, TE671, HT-29) and HUVEC with the following IC(50) values (in muM): 4.3, 6.5, 7.0 and 2.8, respectively. Thus, the antiproliferative potential of parthenolide was confirmed.
Parada-Turska
Jolanta
J
Department of Rheumatology and Connective Tissue Diseases, Medical University, Jaczewskiego 8, PL 20-090 Lublin, Poland. jolanta.turska@am.lublin.pl
Paduch
Roman
R
Majdan
Maria
M
Kandefer-Szerszeń
Martyna
M
Rzeski
Wojciech
W
D000970:Antineoplastic Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D042783:Endothelial Cells / Q000166:cytology / Q000187:drug effects*; D006801:Humans; D012717:Sesquiterpenes / Q000494:pharmacology*; D014471:Umbilical Veins / Q000166:cytology
D000970:Antineoplastic Agents; D012717:Sesquiterpenes; C002669:parthenolide